skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Hepatopathy following irradiation and adriamycin

Journal Article · · Cancer; (United States)

This report describes two cases of hepatopathy following irradiation and adriamycin at doses and volumes of irradiation ordinarily considered within the tolerance of hepatic function. In one case, fatal hepatopathy followed 2400 rad/17 fractions/28 days to the entire liver with preceding and concurrent adriamycin. In the second case moderate clinical changes occurred after treatment in which much of the right lobe of the liver was shielded following 2500 rad/23 fractions/32 days with adriamycin administered before, during, and after irradiation. The locally enhancing effects of adriamycin on hepatic tolerance to irradiation are discussed.

Research Organization:
Midwest Childhood Cancer Center, Milwaukee
OSTI ID:
6751948
Journal Information:
Cancer; (United States), Vol. 42:1
Country of Publication:
United States
Language:
English